F. L. Muiswinkel

发表

Inflammation and Alzheimer’s disease

C. Plata-salamán, C. Finch, H. Hampel, 2000, Neurobiology of Aging.

Role and regulation of early complement activation products in Alzheimer’s disease

R. Veerhuis, P. Eikelenboom, F. L. Muiswinkel, 2001 .

Repeated administration of a selective dopamine D2 receptor agonist to 6-OHDA — lesioned rats does not affect the survival and outgrowth of intrastriatal fetal mesencephalic grafts

J. C. Stoof, J. Ruijter, J. Bol, 2004, Experimental Brain Research.

Do Nonsteroidal Anti-Inflammatory Drugs Have a Protective Effect Against Dementia?

P. Eikelenboom, F. L. Muiswinkel, 1996, Drugs & aging.

Chronic Dopamine D2 Receptor Activation Does Not Affect Survival and Differentiation of Cultured Dopaminergic Neurons: Morphological and Neurochemical Observations

J. C. Stoof, F. L. Muiswinkel, B. Drukarch, 1993, Journal of neurochemistry.

Open peer commentary Inflammation and Alzheimer's disease

C. Finch, H. Hampel, G. Cole, 2000 .

Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor

R. Veerhuis, C. Hack, P. Eikelenboom, 1999, Experimental Neurology.

Inflammation and Alzheimer's Disease: Relationships between Pathogenic Mechanisms and Clinical Expression

P. Eikelenboom, F. L. Muiswinkel, J. Rozemuller, 1998, Experimental Neurology.

Acute or chronic administration of okadaic acid to rats induces brain damage rather than Alzheimer-like neuropathology

J. Bol, F. L. Muiswinkel, R. Binnekade, 1998, Neuroscience.

The amino-terminus of the amyloid-β protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages

P. Eikelenboom, F. L. Muiswinkel, J. Verhoef, 1999, Journal of Neuroimmunology.

Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra

J. Bol, F. L. Muiswinkel, R. Vos, 2004, Neurobiology of Aging.

Identification of NO‐producing and ‐receptive Cells in Mesencephalic Transplants in a Rat Model of Parkinson's Disease: A Study Using NADPH‐d Enzyme‐ and NOSc/cGMP Immunocytochemistry

H. Steinbusch, J. Vente, F. L. Muiswinkel, 1994, Annals of the New York Academy of Sciences.

Drug treatment of Parkinson's disease. Time for phase II.

F. L. Muiswinkel, F. L. van Muiswinkel, B. Drukarch, 2000, Biochemical pharmacology.

Activation of human macrophages by amyloid-beta is attenuated by astrocytes.

F. L. Muiswinkel, J. Verhoef, F. L. van Muiswinkel, 2001, Journal of immunology.